Sensei Biotherapeutics, Inc. (SNSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.45M |
| Enterprise Value | 6.29M |
| P/E Ratio | -0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | -5.28 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 25.9 |
| Enterprise/EBITDA | 0.68 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 38.02 |
| Operating Margin | 38.27 |
| Return On Assets | -0.9 |
| Return On Equity | -2.84 |
| Revenue | 0 |
| Revenue/Share | -3.75 |
| Gross Profit | 0 |
| EBITDA | -20.91M |
| Net Income | -21.09M |
| Diluted EPS | -16.72 |
| Total Cash | 202.79M |
| Total Cash/Share | 156.59 |
| Total Debt | 1.04M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 14.39 |
| Book Value Per Share | 147.63 |
| 52-Week Change | 71.84 |
| 52-Week High | 36.76 |
| 52-Week Low | 6.33 |
| Moving Average 50 Days | 22.11 |
| Moving Average 200 Days | 16.41 |
| Average Volume | 52,120 |
| Shares Outstanding | 1.34M |
| % Held by Institutions | 194.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 17, 2025 |